Identity & origin
BOTANICAL IDENTITY
The right name is the first step.
Aristolochia clematitis L. belongs to Aristolochiaceae. Kew records it as a perennial. The full botanical name and listed organ define this notice; properties of a neighbouring species are not transferred.
Also known as: No synonyms listed.
The full botanical name and listed organ define this notice; properties of a neighbouring species are not transferred. A photograph alone cannot establish identification for consumption.
An illustration is not enough to identify a plant for consumption. Do not forage for a species based solely on this profile.
Uses & evidence
UNDERSTANDING THE USES
Properties & uses.
Documentary reference — leaf
ANSM lists Aristolochia clematitis for the following material: leaf. Inclusion in List B signals that potential adverse effects outweigh the expected therapeutic benefit. The entry does not establish clinical efficacy.
The references do not establish a benefit. Lack of evidence is not assurance of safety.
Read the sourceThe traditional uses described are not clinical proof of effectiveness. Evidence for one preparation cannot automatically be applied to another.
Precautions before use
BEFORE ANY USE
Precautions & contraindications.
This guidance does not cover every individual situation. Missing information is not a guarantee of safety.
The following warnings do not constitute a complete review of interactions or contraindications. An unstudied combination cannot be considered compatible.
Contraindications & precautions
- Safety precaution: do not use this material for self-medication or in a home preparation.
Medicine interactions
- Interactions specific to this species and each preparation are not established by this notice’s documentary sources. This does not establish compatibility with medicines.
“Reported” does not prove causality; “possible” may reflect indirect evidence. “None reported” means none in the cited source, not that all combinations have been studied. Do not stop a prescribed treatment based on this profile.
Adverse effects
- Kidney injury; urinary-tract cancers reported following exposure to products containing aristolochic acids.
Pregnancy & breastfeeding
Pregnancy and breastfeeding: no home use is proposed; this notice does not establish evidence supporting use in these situations.
Children & adolescents
Do not give to children on the basis of this notice. A botanical inventory is not a paediatric safety evaluation.
If symptoms persist, worsen or are unusual, consult a healthcare professional. In an emergency, contact the emergency services.
Available evidence
EXPLORE THE EVIDENCE
The available evidence.
This toxicological dossier concerns Aristolochia clematitis L.. Kidney injury; urinary-tract cancers reported following exposure to products containing aristolochic acids. These risks support caution, not a therapeutic benefit.
Constituents to know.
Their presence and quantity depend on the plant part and preparation.
- Acides aristolochiques / Aristolochic acids
- NCI identifies Aristolochia clematitis as a plant containing these compounds.Read the reference
Kidney and cancer risk
Exposure to herbal products containing aristolochic acids is associated with kidney injury and urinary-tract cancers. NCI advises avoiding such products.
This entry describes a risk or interaction, not a beneficial property.
Read the referenceLimitations to keep in mind.
Do not consume or prepare the plant at home. After suspected exposure, seek poison-centre advice; breathing, neurological or cardiovascular symptoms require urgent help.
Studies, findings & limitations
THE RESEARCH
What the research shows.
A laboratory or animal result alone does not demonstrate a benefit in humans. Each result must be read alongside the preparation studied and its limitations.
National Cancer Institute — Aristolochic Acids
This entry describes a risk or interaction, not a beneficial property.
- Type of research
- Institutional or university toxicology summary; this document is not an efficacy trial.
- Preparation concerned
- Exposures and products described by the source; no home dose or preparation is inferred.
- Observed results
- Exposure to herbal products containing aristolochic acids is associated with kidney injury and urinary-tract cancers. NCI advises avoiding such products.
- Limitations to consider
- The document identifies risks, does not systematically measure their frequency and establishes no safe quantity. Risks are not therapeutic properties.
What can we take from this?
“Insufficient evidence” refers to establishing therapeutic benefit and use, not to absence of the described risk. This notice does not replace individual toxicological assessment or establish a safe quantity.
Documentary review dated 09/10/2026. The references remain available to check the context.
Sources & last review
CHECKING REFERENCES
Sources for this profile.
- ANSM — French Pharmacopoeia, List B, January 2026, p. 2Accessed on 09/10/2026
- Royal Botanic Gardens, Kew — Plants of the World Online : Aristolochia clematitis L.Accessed on 09/10/2026
- National Cancer Institute — Aristolochic AcidsAccessed on 09/10/2026
Image: Dmitry Trutsko · CC BY 4.0. View the original image and its licence. Image resized and converted to WebP.